| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Animal | 86 | 2022 | 482 | 11.500 |
Why?
|
| Breast Neoplasms | 50 | 2024 | 2480 | 5.320 |
Why?
|
| Neoplastic Stem Cells | 24 | 2023 | 295 | 5.140 |
Why?
|
| Triple Negative Breast Neoplasms | 12 | 2024 | 219 | 4.950 |
Why?
|
| Mammary Neoplasms, Animal | 15 | 2021 | 138 | 3.770 |
Why?
|
| Mammary Glands, Human | 13 | 2014 | 80 | 3.560 |
Why?
|
| Stem Cells | 18 | 2017 | 710 | 3.350 |
Why?
|
| Epithelial Cells | 36 | 2022 | 907 | 3.250 |
Why?
|
| Caseins | 39 | 2011 | 62 | 2.960 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 13 | 2018 | 66 | 2.900 |
Why?
|
| Mammary Neoplasms, Experimental | 24 | 2015 | 245 | 2.590 |
Why?
|
| Breast | 10 | 2022 | 214 | 2.450 |
Why?
|
| Tumor Microenvironment | 14 | 2024 | 548 | 2.430 |
Why?
|
| Mice | 127 | 2024 | 17548 | 2.340 |
Why?
|
| Animals | 185 | 2024 | 33723 | 2.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 23 | 2023 | 1890 | 2.230 |
Why?
|
| RNA, Long Noncoding | 5 | 2023 | 210 | 1.870 |
Why?
|
| Cell Differentiation | 20 | 2020 | 1935 | 1.870 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 8 | 2020 | 37 | 1.860 |
Why?
|
| Wnt Signaling Pathway | 10 | 2022 | 199 | 1.750 |
Why?
|
| Signal Transduction | 31 | 2022 | 4510 | 1.740 |
Why?
|
| Milk Proteins | 20 | 2007 | 90 | 1.730 |
Why?
|
| MicroRNAs | 9 | 2021 | 839 | 1.690 |
Why?
|
| Epithelial-Mesenchymal Transition | 9 | 2022 | 218 | 1.670 |
Why?
|
| Prolactin | 18 | 2011 | 104 | 1.490 |
Why?
|
| Cell Transformation, Neoplastic | 17 | 2022 | 630 | 1.480 |
Why?
|
| Wnt Proteins | 7 | 2013 | 199 | 1.390 |
Why?
|
| Protein Kinases | 6 | 2011 | 329 | 1.380 |
Why?
|
| DNA Damage | 10 | 2020 | 516 | 1.290 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 259 | 1.290 |
Why?
|
| Neoplasm Metastasis | 9 | 2024 | 650 | 1.250 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2022 | 36 | 1.250 |
Why?
|
| Radiation Tolerance | 4 | 2010 | 53 | 1.250 |
Why?
|
| RNA, Untranslated | 5 | 2012 | 114 | 1.240 |
Why?
|
| beta Catenin | 10 | 2023 | 208 | 1.200 |
Why?
|
| Female | 137 | 2024 | 64882 | 1.190 |
Why?
|
| Myeloid-Derived Suppressor Cells | 6 | 2021 | 49 | 1.190 |
Why?
|
| GTPase-Activating Proteins | 6 | 2011 | 85 | 1.180 |
Why?
|
| Ecosystem | 3 | 2023 | 76 | 1.160 |
Why?
|
| Antineoplastic Agents | 6 | 2024 | 1680 | 1.150 |
Why?
|
| RNA, Messenger | 39 | 2020 | 2826 | 1.140 |
Why?
|
| Mesoderm | 6 | 2021 | 117 | 1.110 |
Why?
|
| Tumor Suppressor Protein p53 | 11 | 2017 | 712 | 1.100 |
Why?
|
| Cell Proliferation | 20 | 2024 | 2313 | 1.090 |
Why?
|
| Gene Expression Profiling | 17 | 2016 | 1674 | 1.080 |
Why?
|
| STAT5 Transcription Factor | 14 | 2022 | 89 | 1.070 |
Why?
|
| Cell Line, Tumor | 25 | 2024 | 3292 | 1.060 |
Why?
|
| Adenocarcinoma | 10 | 2023 | 1001 | 1.020 |
Why?
|
| Macrophages | 6 | 2022 | 611 | 1.010 |
Why?
|
| Receptors, Progesterone | 11 | 2015 | 865 | 1.010 |
Why?
|
| Homeostasis | 4 | 2017 | 680 | 0.970 |
Why?
|
| CREB-Binding Protein | 1 | 2024 | 64 | 0.940 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 6 | 2014 | 35 | 0.930 |
Why?
|
| Carcinoma | 2 | 2020 | 282 | 0.910 |
Why?
|
| Cell Lineage | 7 | 2017 | 348 | 0.900 |
Why?
|
| Cell Self Renewal | 3 | 2018 | 41 | 0.880 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2014 | 1003 | 0.840 |
Why?
|
| Epithelium | 15 | 2015 | 372 | 0.840 |
Why?
|
| Neutrophils | 2 | 2024 | 372 | 0.830 |
Why?
|
| Neoplasms | 10 | 2023 | 2753 | 0.830 |
Why?
|
| Trans-Activators | 10 | 2016 | 804 | 0.810 |
Why?
|
| Mice, Inbred BALB C | 15 | 2021 | 980 | 0.810 |
Why?
|
| Humans | 99 | 2024 | 122292 | 0.800 |
Why?
|
| Progesterone | 10 | 2015 | 624 | 0.790 |
Why?
|
| Mice, Knockout | 18 | 2020 | 3770 | 0.790 |
Why?
|
| Estrogens | 7 | 2015 | 506 | 0.780 |
Why?
|
| Repressor Proteins | 6 | 2014 | 808 | 0.780 |
Why?
|
| Biomarkers, Tumor | 6 | 2020 | 1424 | 0.780 |
Why?
|
| Disease Models, Animal | 14 | 2024 | 4282 | 0.770 |
Why?
|
| Wnt1 Protein | 5 | 2019 | 71 | 0.750 |
Why?
|
| 5' Untranslated Regions | 2 | 2018 | 59 | 0.750 |
Why?
|
| Mammary Tumor Virus, Mouse | 8 | 2019 | 106 | 0.750 |
Why?
|
| Receptors, Glucocorticoid | 7 | 2011 | 123 | 0.740 |
Why?
|
| ErbB Receptors | 4 | 2019 | 282 | 0.730 |
Why?
|
| Cell Division | 14 | 2015 | 795 | 0.730 |
Why?
|
| Claudins | 6 | 2022 | 29 | 0.720 |
Why?
|
| Mice, Transgenic | 24 | 2017 | 2440 | 0.720 |
Why?
|
| Apoptosis | 13 | 2021 | 1790 | 0.710 |
Why?
|
| Transcription, Genetic | 20 | 2020 | 1703 | 0.700 |
Why?
|
| Protein Biosynthesis | 11 | 2018 | 668 | 0.700 |
Why?
|
| Paracrine Communication | 4 | 2015 | 71 | 0.680 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 666 | 0.670 |
Why?
|
| Spindle Apparatus | 3 | 2015 | 60 | 0.660 |
Why?
|
| Chromosome Segregation | 2 | 2009 | 58 | 0.650 |
Why?
|
| Stromal Cells | 4 | 2015 | 296 | 0.640 |
Why?
|
| Cell Polarity | 4 | 2016 | 123 | 0.640 |
Why?
|
| Gene Expression Regulation | 15 | 2012 | 2534 | 0.640 |
Why?
|
| Organoids | 1 | 2021 | 276 | 0.620 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 10 | 0.620 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2020 | 546 | 0.620 |
Why?
|
| Neoplasm Proteins | 7 | 2021 | 666 | 0.610 |
Why?
|
| DNA-Binding Proteins | 12 | 2020 | 2029 | 0.610 |
Why?
|
| Dishevelled Proteins | 2 | 2017 | 43 | 0.600 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 95 | 0.580 |
Why?
|
| Cell Movement | 5 | 2020 | 838 | 0.570 |
Why?
|
| rho-Associated Kinases | 1 | 2017 | 55 | 0.560 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2017 | 38 | 0.560 |
Why?
|
| Cell Separation | 7 | 2019 | 237 | 0.560 |
Why?
|
| Receptors, Estrogen | 7 | 2015 | 788 | 0.550 |
Why?
|
| DNA Repair | 4 | 2015 | 583 | 0.550 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2017 | 68 | 0.550 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 122 | 0.540 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2022 | 1118 | 0.530 |
Why?
|
| Antigens, Ly | 3 | 2011 | 32 | 0.530 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2015 | 262 | 0.520 |
Why?
|
| Carboplatin | 2 | 2015 | 78 | 0.510 |
Why?
|
| Immunotherapy | 2 | 2019 | 658 | 0.510 |
Why?
|
| Rats | 35 | 2012 | 3657 | 0.500 |
Why?
|
| Models, Biological | 11 | 2020 | 1438 | 0.500 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2024 | 875 | 0.490 |
Why?
|
| Actin Cytoskeleton | 1 | 2015 | 43 | 0.490 |
Why?
|
| Cell Adhesion | 6 | 2022 | 321 | 0.480 |
Why?
|
| Pregnancy | 31 | 2015 | 7092 | 0.470 |
Why?
|
| Doxorubicin | 2 | 2015 | 307 | 0.460 |
Why?
|
| Hormones | 7 | 2010 | 189 | 0.460 |
Why?
|
| Receptors, Notch | 3 | 2015 | 206 | 0.440 |
Why?
|
| Phosphoproteins | 5 | 2016 | 400 | 0.430 |
Why?
|
| Up-Regulation | 2 | 2015 | 873 | 0.430 |
Why?
|
| Base Sequence | 25 | 2011 | 3109 | 0.420 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2019 | 525 | 0.420 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2012 | 6 | 0.420 |
Why?
|
| YY1 Transcription Factor | 2 | 2009 | 12 | 0.400 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1678 | 0.400 |
Why?
|
| Oncogenes | 5 | 2015 | 172 | 0.390 |
Why?
|
| Checkpoint Kinase 1 | 6 | 2011 | 25 | 0.390 |
Why?
|
| Transcription Factors | 7 | 2020 | 2577 | 0.390 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2013 | 1000 | 0.380 |
Why?
|
| Haplotypes | 2 | 2010 | 510 | 0.370 |
Why?
|
| Neoplasm Transplantation | 7 | 2014 | 375 | 0.370 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2020 | 297 | 0.370 |
Why?
|
| Phosphorylation | 12 | 2014 | 1613 | 0.370 |
Why?
|
| Endoribonucleases | 2 | 2024 | 83 | 0.370 |
Why?
|
| Nanoshells | 1 | 2010 | 13 | 0.370 |
Why?
|
| cdc25 Phosphatases | 3 | 2005 | 22 | 0.370 |
Why?
|
| Neoplasms, Experimental | 2 | 2011 | 215 | 0.360 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2021 | 204 | 0.360 |
Why?
|
| Hyperthermia, Induced | 1 | 2010 | 45 | 0.360 |
Why?
|
| Gold | 1 | 2010 | 50 | 0.350 |
Why?
|
| Membrane Proteins | 5 | 2011 | 1520 | 0.350 |
Why?
|
| Erythropoiesis | 1 | 2010 | 40 | 0.340 |
Why?
|
| DNA Replication | 2 | 2009 | 345 | 0.340 |
Why?
|
| Mice, SCID | 6 | 2014 | 570 | 0.330 |
Why?
|
| Oncogene Proteins | 1 | 2010 | 140 | 0.330 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 67 | 0.330 |
Why?
|
| Biology | 1 | 2009 | 28 | 0.330 |
Why?
|
| Myeloid Cells | 3 | 2019 | 100 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2011 | 1296 | 0.330 |
Why?
|
| Cytokinesis | 1 | 2009 | 27 | 0.330 |
Why?
|
| Receptors, Fibroblast Growth Factor | 4 | 2003 | 60 | 0.320 |
Why?
|
| Protein Isoforms | 4 | 2020 | 408 | 0.320 |
Why?
|
| Cell Line | 12 | 2020 | 2782 | 0.320 |
Why?
|
| Genomic Instability | 2 | 2011 | 229 | 0.320 |
Why?
|
| NFI Transcription Factors | 2 | 2007 | 50 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 4366 | 0.320 |
Why?
|
| Aging | 1 | 2015 | 1165 | 0.310 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 114 | 0.310 |
Why?
|
| Cell Cycle | 6 | 2016 | 618 | 0.310 |
Why?
|
| Osteosarcoma | 1 | 2011 | 258 | 0.310 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2003 | 133 | 0.310 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2008 | 84 | 0.300 |
Why?
|
| Disease Progression | 8 | 2019 | 1990 | 0.300 |
Why?
|
| Lactation | 13 | 2015 | 185 | 0.300 |
Why?
|
| Cells, Cultured | 8 | 2014 | 3074 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 8 | 2013 | 1354 | 0.290 |
Why?
|
| Pyrimidines | 3 | 2021 | 376 | 0.290 |
Why?
|
| Transfection | 8 | 2018 | 1076 | 0.290 |
Why?
|
| Morphogenesis | 4 | 2015 | 212 | 0.290 |
Why?
|
| Integrases | 4 | 2015 | 162 | 0.280 |
Why?
|
| Keratins | 2 | 2006 | 55 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 493 | 0.280 |
Why?
|
| RNA, Double-Stranded | 2 | 2024 | 63 | 0.280 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2007 | 91 | 0.280 |
Why?
|
| Cyclin D1 | 2 | 2005 | 116 | 0.280 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2010 | 120 | 0.270 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 444 | 0.270 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 282 | 0.270 |
Why?
|
| Glucocorticoids | 1 | 2009 | 379 | 0.270 |
Why?
|
| Neoplasm, Residual | 2 | 2022 | 122 | 0.270 |
Why?
|
| DNA | 16 | 1996 | 1606 | 0.270 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2006 | 92 | 0.270 |
Why?
|
| Transforming Growth Factor beta | 2 | 2006 | 458 | 0.270 |
Why?
|
| Cell Cycle Proteins | 3 | 2014 | 657 | 0.260 |
Why?
|
| Anemia | 1 | 2010 | 338 | 0.260 |
Why?
|
| Flow Cytometry | 8 | 2019 | 810 | 0.260 |
Why?
|
| Precancerous Conditions | 2 | 2006 | 287 | 0.260 |
Why?
|
| Genes | 9 | 1986 | 443 | 0.250 |
Why?
|
| Animals, Genetically Modified | 3 | 2013 | 315 | 0.250 |
Why?
|
| Sexual Maturation | 2 | 2016 | 48 | 0.250 |
Why?
|
| Dimerization | 5 | 2006 | 144 | 0.250 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2016 | 428 | 0.240 |
Why?
|
| Pyroptosis | 1 | 2024 | 20 | 0.240 |
Why?
|
| RNA, Small Interfering | 5 | 2011 | 663 | 0.240 |
Why?
|
| Taxoids | 1 | 2024 | 67 | 0.240 |
Why?
|
| Neoplasms, Hormone-Dependent | 4 | 2015 | 98 | 0.240 |
Why?
|
| Glycoproteins | 1 | 2007 | 371 | 0.230 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2024 | 54 | 0.230 |
Why?
|
| Keratin-8 | 2 | 2015 | 11 | 0.230 |
Why?
|
| RNA Splicing | 4 | 2021 | 223 | 0.230 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 97 | 0.230 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2012 | 468 | 0.230 |
Why?
|
| Receptors, Prolactin | 2 | 2002 | 11 | 0.230 |
Why?
|
| Molecular Targeted Therapy | 3 | 2021 | 352 | 0.220 |
Why?
|
| Cell Size | 3 | 2016 | 81 | 0.220 |
Why?
|
| Genomics | 1 | 2011 | 1458 | 0.220 |
Why?
|
| Down-Regulation | 4 | 2015 | 702 | 0.220 |
Why?
|
| Carcinogenesis | 5 | 2019 | 332 | 0.220 |
Why?
|
| Somatomedins | 1 | 2003 | 36 | 0.220 |
Why?
|
| Interferons | 1 | 2023 | 120 | 0.210 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2021 | 70 | 0.210 |
Why?
|
| Protein Binding | 3 | 2020 | 1732 | 0.210 |
Why?
|
| src-Family Kinases | 1 | 2003 | 83 | 0.210 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 268 | 0.210 |
Why?
|
| Mitosis | 5 | 2020 | 239 | 0.200 |
Why?
|
| Recombinant Proteins | 4 | 2006 | 1369 | 0.200 |
Why?
|
| Transgenes | 5 | 2012 | 330 | 0.200 |
Why?
|
| Phenotype | 8 | 2019 | 4150 | 0.200 |
Why?
|
| Transplantation, Heterologous | 3 | 2011 | 257 | 0.200 |
Why?
|
| Heterozygote | 3 | 2011 | 675 | 0.200 |
Why?
|
| Jagged-1 Protein | 1 | 2022 | 52 | 0.200 |
Why?
|
| Plasmids | 9 | 2005 | 516 | 0.200 |
Why?
|
| Natural Killer T-Cells | 1 | 2023 | 77 | 0.200 |
Why?
|
| Nucleic Acid Hybridization | 18 | 1985 | 397 | 0.200 |
Why?
|
| Puberty | 2 | 2015 | 94 | 0.200 |
Why?
|
| Cyclophosphamide | 2 | 2022 | 422 | 0.200 |
Why?
|
| Nuclear Proteins | 3 | 2003 | 1277 | 0.190 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 2 | 2012 | 10 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 717 | 0.190 |
Why?
|
| Azacitidine | 1 | 2021 | 56 | 0.190 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 298 | 0.190 |
Why?
|
| Ribosomes | 3 | 2018 | 137 | 0.190 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 10 | 2001 | 56 | 0.190 |
Why?
|
| CD4 Antigens | 1 | 2021 | 56 | 0.190 |
Why?
|
| Platelet Factor 4 | 1 | 2021 | 22 | 0.190 |
Why?
|
| Muscle Proteins | 1 | 2004 | 415 | 0.190 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2020 | 76 | 0.190 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2011 | 23 | 0.190 |
Why?
|
| Leukemia | 1 | 2004 | 375 | 0.190 |
Why?
|
| CD8 Antigens | 1 | 2021 | 43 | 0.190 |
Why?
|
| Genes, p53 | 4 | 2010 | 215 | 0.190 |
Why?
|
| Benzamides | 1 | 2021 | 108 | 0.180 |
Why?
|
| Databases, Genetic | 1 | 2003 | 463 | 0.180 |
Why?
|
| Spliceosomes | 1 | 2021 | 48 | 0.180 |
Why?
|
| Blotting, Western | 4 | 2011 | 1104 | 0.180 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 31 | 0.180 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 22 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1614 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 187 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2006 | 1015 | 0.180 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 54 | 0.180 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2020 | 19 | 0.180 |
Why?
|
| DNA Transposable Elements | 2 | 2020 | 178 | 0.180 |
Why?
|
| Biomarkers | 4 | 2021 | 2933 | 0.180 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2007 | 78 | 0.180 |
Why?
|
| Cell Survival | 4 | 2009 | 816 | 0.180 |
Why?
|
| Receptor, ErbB-2 | 4 | 2010 | 497 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 123 | 0.170 |
Why?
|
| Heterografts | 3 | 2015 | 184 | 0.170 |
Why?
|
| Immunoenzyme Techniques | 3 | 2010 | 268 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2014 | 557 | 0.170 |
Why?
|
| Transplants | 1 | 2020 | 36 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 182 | 0.170 |
Why?
|
| RNA Stability | 1 | 2020 | 85 | 0.170 |
Why?
|
| Organogenesis | 2 | 2010 | 78 | 0.170 |
Why?
|
| Proteostasis | 1 | 2020 | 35 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 3 | 2013 | 1750 | 0.170 |
Why?
|
| Chromatin | 4 | 2011 | 552 | 0.170 |
Why?
|
| Aurora Kinase B | 2 | 2009 | 8 | 0.170 |
Why?
|
| Transcriptional Activation | 5 | 2011 | 483 | 0.170 |
Why?
|
| Aurora Kinases | 2 | 2009 | 31 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2007 | 768 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 213 | 0.170 |
Why?
|
| DNA Primers | 3 | 2011 | 668 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2017 | 43 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 517 | 0.170 |
Why?
|
| Colony-Forming Units Assay | 2 | 2010 | 70 | 0.160 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 506 | 0.160 |
Why?
|
| Gene Expression | 6 | 2013 | 1579 | 0.160 |
Why?
|
| Estradiol | 6 | 2002 | 534 | 0.160 |
Why?
|
| Mice, Nude | 3 | 2021 | 697 | 0.160 |
Why?
|
| Quinazolines | 3 | 2015 | 176 | 0.160 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2019 | 58 | 0.160 |
Why?
|
| Mice, Inbred NOD | 3 | 2021 | 285 | 0.160 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 388 | 0.160 |
Why?
|
| Cattle | 5 | 2006 | 555 | 0.160 |
Why?
|
| Zebrafish Proteins | 2 | 2003 | 104 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 570 | 0.160 |
Why?
|
| Tyrosine | 1 | 1999 | 167 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2010 | 461 | 0.160 |
Why?
|
| Triterpenes | 1 | 2018 | 21 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 2 | 2003 | 153 | 0.150 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2012 | 93 | 0.150 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 503 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 398 | 0.150 |
Why?
|
| Homozygote | 2 | 2011 | 521 | 0.150 |
Why?
|
| Spheroids, Cellular | 3 | 2014 | 59 | 0.150 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 29 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 2797 | 0.150 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2017 | 20 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 346 | 0.150 |
Why?
|
| Response Elements | 1 | 2018 | 99 | 0.150 |
Why?
|
| RNA Helicases | 1 | 2018 | 61 | 0.150 |
Why?
|
| Gene Knockout Techniques | 2 | 2021 | 127 | 0.150 |
Why?
|
| Lentivirus | 3 | 2014 | 84 | 0.150 |
Why?
|
| Hydrocortisone | 9 | 2011 | 215 | 0.150 |
Why?
|
| Receptors, Steroid | 2 | 2011 | 269 | 0.150 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 167 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 239 | 0.140 |
Why?
|
| In Situ Hybridization | 2 | 2011 | 474 | 0.140 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 3865 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 181 | 0.140 |
Why?
|
| Genetic Vectors | 4 | 2014 | 969 | 0.140 |
Why?
|
| Collagen | 2 | 2015 | 311 | 0.140 |
Why?
|
| Cell Culture Techniques | 2 | 2009 | 288 | 0.140 |
Why?
|
| Tamoxifen | 2 | 2015 | 363 | 0.140 |
Why?
|
| Cluster Analysis | 3 | 2013 | 386 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 541 | 0.130 |
Why?
|
| Stem Cell Transplantation | 2 | 2015 | 239 | 0.130 |
Why?
|
| Oviducts | 8 | 1977 | 330 | 0.130 |
Why?
|
| Tenascin | 1 | 2015 | 35 | 0.130 |
Why?
|
| Polyribosomes | 2 | 2010 | 25 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 351 | 0.130 |
Why?
|
| CD24 Antigen | 3 | 2013 | 30 | 0.130 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 48 | 0.130 |
Why?
|
| Sialoglycoproteins | 2 | 2006 | 48 | 0.120 |
Why?
|
| Cloning, Molecular | 6 | 1986 | 887 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2020 | 621 | 0.120 |
Why?
|
| Cell Line, Transformed | 3 | 2013 | 172 | 0.120 |
Why?
|
| Cell Shape | 1 | 2015 | 61 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 138 | 0.120 |
Why?
|
| Integrin beta1 | 3 | 2013 | 54 | 0.120 |
Why?
|
| Cellular Senescence | 3 | 2011 | 159 | 0.120 |
Why?
|
| Antigens, Surface | 1 | 2015 | 122 | 0.120 |
Why?
|
| Hyperplasia | 3 | 2016 | 214 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2012 | 121 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2015 | 427 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2015 | 235 | 0.120 |
Why?
|
| Amino Acid Sequence | 7 | 2012 | 2674 | 0.120 |
Why?
|
| RNA Interference | 3 | 2011 | 496 | 0.120 |
Why?
|
| Immunophenotyping | 1 | 2015 | 333 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 1250 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 102 | 0.110 |
Why?
|
| Structure-Activity Relationship | 3 | 2012 | 570 | 0.110 |
Why?
|
| Osteogenesis | 1 | 2015 | 154 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2017 | 741 | 0.110 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2013 | 10 | 0.110 |
Why?
|
| Biological Evolution | 3 | 1986 | 221 | 0.110 |
Why?
|
| DNA Copy Number Variations | 3 | 2016 | 928 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 240 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 751 | 0.110 |
Why?
|
| Histones | 3 | 2010 | 530 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 369 | 0.110 |
Why?
|
| Precision Medicine | 1 | 2016 | 306 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2005 | 108 | 0.100 |
Why?
|
| Lactalbumin | 3 | 1981 | 11 | 0.100 |
Why?
|
| Polycomb-Group Proteins | 1 | 2012 | 18 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 217 | 0.100 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1067 | 0.100 |
Why?
|
| COS Cells | 3 | 2006 | 273 | 0.100 |
Why?
|
| Tacrolimus | 2 | 2003 | 98 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2013 | 236 | 0.100 |
Why?
|
| Collagen Type IV | 1 | 2011 | 20 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2024 | 122 | 0.100 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 57 | 0.100 |
Why?
|
| Organic Chemicals | 1 | 2011 | 59 | 0.100 |
Why?
|
| Fibronectins | 1 | 2011 | 104 | 0.100 |
Why?
|
| RNA, Neoplasm | 3 | 1981 | 138 | 0.100 |
Why?
|
| Collagen Type I | 1 | 2011 | 110 | 0.100 |
Why?
|
| Poly A | 6 | 1986 | 60 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 29 | 0.090 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2010 | 9 | 0.090 |
Why?
|
| DNA, Recombinant | 2 | 1981 | 105 | 0.090 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2010 | 12 | 0.090 |
Why?
|
| Aging, Premature | 1 | 2011 | 32 | 0.090 |
Why?
|
| Cell Nucleolus | 1 | 2011 | 56 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2010 | 42 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 79 | 0.090 |
Why?
|
| Chromosomes | 2 | 2009 | 199 | 0.090 |
Why?
|
| Prostatic Neoplasms | 3 | 2003 | 1516 | 0.090 |
Why?
|
| Genetic Techniques | 1 | 2011 | 102 | 0.090 |
Why?
|
| Rats, Inbred Strains | 7 | 1985 | 229 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 391 | 0.090 |
Why?
|
| Cadherins | 2 | 2015 | 164 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 428 | 0.090 |
Why?
|
| Cell Dedifferentiation | 1 | 2010 | 21 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2010 | 42 | 0.090 |
Why?
|
| Phosphorylcholine | 1 | 2010 | 26 | 0.090 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 63 | 0.090 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 374 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 261 | 0.090 |
Why?
|
| Cell Communication | 2 | 2011 | 165 | 0.090 |
Why?
|
| Kinetics | 9 | 2016 | 1315 | 0.090 |
Why?
|
| Embryo, Mammalian | 2 | 2011 | 452 | 0.090 |
Why?
|
| Staurosporine | 2 | 2011 | 21 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2011 | 312 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 347 | 0.080 |
Why?
|
| Mutation | 5 | 2017 | 5734 | 0.080 |
Why?
|
| Pregnancy, Animal | 2 | 2001 | 74 | 0.080 |
Why?
|
| Thrombospondin 1 | 1 | 2009 | 22 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 197 | 0.080 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 124 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2021 | 291 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 160 | 0.080 |
Why?
|
| In Vitro Techniques | 5 | 2007 | 968 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2011 | 459 | 0.080 |
Why?
|
| Mammals | 2 | 2006 | 261 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 241 | 0.080 |
Why?
|
| Genome, Human | 2 | 2017 | 1248 | 0.080 |
Why?
|
| Carcinoma, Ductal | 1 | 2009 | 8 | 0.080 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 317 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2009 | 37 | 0.080 |
Why?
|
| Gene Amplification | 3 | 2021 | 228 | 0.080 |
Why?
|
| Osteopontin | 2 | 2006 | 49 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 609 | 0.080 |
Why?
|
| HeLa Cells | 3 | 2011 | 808 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 1592 | 0.080 |
Why?
|
| Cyclin E | 2 | 2005 | 30 | 0.080 |
Why?
|
| Genes, ras | 2 | 2019 | 96 | 0.080 |
Why?
|
| Multigene Family | 2 | 2003 | 299 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 287 | 0.080 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 45 | 0.080 |
Why?
|
| Cell Transplantation | 1 | 2008 | 54 | 0.080 |
Why?
|
| Carcinoma in Situ | 1 | 2009 | 69 | 0.080 |
Why?
|
| Genes, Reporter | 3 | 2014 | 384 | 0.080 |
Why?
|
| Cell Count | 2 | 2020 | 250 | 0.080 |
Why?
|
| Ovalbumin | 5 | 1977 | 316 | 0.080 |
Why?
|
| Cell-Matrix Junctions | 2 | 2022 | 8 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 2 | 2006 | 209 | 0.070 |
Why?
|
| Diethylstilbestrol | 4 | 1975 | 142 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 384 | 0.070 |
Why?
|
| Acetylglucosamine | 1 | 2007 | 6 | 0.070 |
Why?
|
| Transcriptome | 1 | 2013 | 904 | 0.070 |
Why?
|
| Ovary | 1 | 2010 | 390 | 0.070 |
Why?
|
| Computational Biology | 3 | 2017 | 789 | 0.070 |
Why?
|
| Threonine | 1 | 2007 | 60 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2007 | 9 | 0.070 |
Why?
|
| EGF Family of Proteins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Amphiregulin | 1 | 2007 | 12 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 37 | 0.070 |
Why?
|
| Glycosylation | 1 | 2007 | 110 | 0.070 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 43 | 0.070 |
Why?
|
| Organ Culture Techniques | 6 | 2002 | 155 | 0.070 |
Why?
|
| Keratin-6 | 1 | 2006 | 13 | 0.070 |
Why?
|
| Acetylcysteine | 1 | 2007 | 74 | 0.070 |
Why?
|
| Serpins | 1 | 2006 | 27 | 0.070 |
Why?
|
| Nucleic Acid Precursors | 1 | 1986 | 16 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1710 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2021 | 1468 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2003 | 1076 | 0.070 |
Why?
|
| Gene Dosage | 2 | 2020 | 439 | 0.070 |
Why?
|
| Neoadjuvant Therapy | 1 | 2008 | 326 | 0.070 |
Why?
|
| Parity | 3 | 2003 | 79 | 0.070 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2005 | 16 | 0.070 |
Why?
|
| RNA Polymerase II | 1 | 2006 | 100 | 0.070 |
Why?
|
| Forecasting | 1 | 2007 | 355 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2005 | 46 | 0.060 |
Why?
|
| Drug Resistance, Multiple | 1 | 2005 | 50 | 0.060 |
Why?
|
| DNA, Neoplasm | 3 | 1972 | 303 | 0.060 |
Why?
|
| Fibroblasts | 4 | 2019 | 878 | 0.060 |
Why?
|
| Genes, Homeobox | 1 | 2005 | 70 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 279 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 114 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 241 | 0.060 |
Why?
|
| Protein Transport | 2 | 2020 | 369 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 1972 | 162 | 0.060 |
Why?
|
| Binding Sites | 3 | 2003 | 1292 | 0.060 |
Why?
|
| Bridged-Ring Compounds | 1 | 2024 | 16 | 0.060 |
Why?
|
| S Phase | 1 | 2004 | 73 | 0.060 |
Why?
|
| RNA | 4 | 1981 | 578 | 0.060 |
Why?
|
| Species Specificity | 4 | 2015 | 550 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2003 | 320 | 0.060 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2003 | 43 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2006 | 346 | 0.060 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 102 | 0.060 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2024 | 112 | 0.060 |
Why?
|
| Male | 10 | 2020 | 59517 | 0.060 |
Why?
|
| Benz(a)Anthracenes | 1 | 1983 | 3 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 90 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 83 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 104 | 0.050 |
Why?
|
| Time Factors | 6 | 2013 | 6181 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1999 | 312 | 0.050 |
Why?
|
| Prostatic Hyperplasia | 1 | 2003 | 107 | 0.050 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2023 | 12 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 60 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 8 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 352 | 0.050 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2002 | 19 | 0.050 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 23 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 174 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2003 | 122 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2003 | 291 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2003 | 156 | 0.050 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2002 | 45 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2024 | 149 | 0.050 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2002 | 16 | 0.050 |
Why?
|
| Molecular Weight | 6 | 1986 | 390 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 654 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2004 | 348 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 276 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 81 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2001 | 351 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2002 | 150 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2003 | 613 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2002 | 66 | 0.050 |
Why?
|
| Wound Healing | 1 | 2005 | 454 | 0.050 |
Why?
|
| Codon | 2 | 1997 | 97 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 1 | 2021 | 15 | 0.050 |
Why?
|
| Chickens | 7 | 2010 | 637 | 0.050 |
Why?
|
| Phylogeny | 1 | 2003 | 681 | 0.050 |
Why?
|
| Prognosis | 1 | 2010 | 4488 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2003 | 831 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 213 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 1004 | 0.050 |
Why?
|
| Body Patterning | 2 | 2016 | 122 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2023 | 680 | 0.050 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 17 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 353 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 8 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 89 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 1084 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 37 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 669 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 303 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 4 | 1984 | 121 | 0.040 |
Why?
|
| Cricetinae | 2 | 1999 | 403 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 65 | 0.040 |
Why?
|
| Half-Life | 3 | 1985 | 159 | 0.040 |
Why?
|
| Lithium Chloride | 1 | 2019 | 8 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2003 | 706 | 0.040 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 63 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2019 | 77 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1392 | 0.040 |
Why?
|
| CHO Cells | 1 | 1999 | 158 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 84 | 0.040 |
Why?
|
| Tritium | 7 | 1974 | 174 | 0.040 |
Why?
|
| Cocarcinogenesis | 1 | 1998 | 23 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 325 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 54 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 523 | 0.040 |
Why?
|
| Calcium | 1 | 1982 | 1095 | 0.040 |
Why?
|
| Glucose | 3 | 1972 | 875 | 0.040 |
Why?
|
| Hexoses | 3 | 1972 | 11 | 0.040 |
Why?
|
| Carcinogens | 1 | 1998 | 152 | 0.040 |
Why?
|
| Pyrroles | 1 | 2019 | 177 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2017 | 211 | 0.040 |
Why?
|
| Gene Library | 1 | 2017 | 219 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2016 | 42 | 0.030 |
Why?
|
| Enzymes | 1 | 1996 | 51 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 98 | 0.030 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2015 | 7 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 96 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 165 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 370 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 4 | 1983 | 97 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 447 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 69 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 414 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 1996 | 159 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 1227 | 0.030 |
Why?
|
| Pyridines | 1 | 2016 | 222 | 0.030 |
Why?
|
| Genetic Code | 1 | 1974 | 40 | 0.030 |
Why?
|
| Fluorescence | 1 | 2014 | 93 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2009 | 459 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 17 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 202 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 95 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 38 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 340 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 99 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 170 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1986 | 368 | 0.030 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2013 | 14 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2016 | 300 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 297 | 0.030 |
Why?
|
| Microscopy, Electron | 3 | 1983 | 400 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2013 | 122 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 860 | 0.030 |
Why?
|
| Leukemia L1210 | 1 | 1972 | 4 | 0.030 |
Why?
|
| Cell Nucleus | 4 | 2002 | 678 | 0.030 |
Why?
|
| Dexamethasone | 2 | 1970 | 274 | 0.030 |
Why?
|
| Methylnitrosourea | 2 | 2001 | 19 | 0.030 |
Why?
|
| Daunorubicin | 1 | 1972 | 27 | 0.030 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 2002 | 6 | 0.030 |
Why?
|
| Axin Protein | 1 | 2012 | 17 | 0.030 |
Why?
|
| Casein Kinase I | 1 | 2012 | 12 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2012 | 48 | 0.020 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 100 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 60 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 321 | 0.020 |
Why?
|
| Promegestone | 1 | 2011 | 30 | 0.020 |
Why?
|
| Galactosides | 1 | 2011 | 12 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2012 | 177 | 0.020 |
Why?
|
| Luminescence | 1 | 2011 | 15 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2011 | 28 | 0.020 |
Why?
|
| Progestins | 1 | 2011 | 47 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1972 | 129 | 0.020 |
Why?
|
| G2 Phase | 1 | 2011 | 45 | 0.020 |
Why?
|
| Hexokinase | 1 | 1970 | 20 | 0.020 |
Why?
|
| Goosecoid Protein | 1 | 2010 | 4 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2010 | 31 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2010 | 24 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 131 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 330 | 0.020 |
Why?
|
| Twist-Related Protein 1 | 1 | 2010 | 36 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 186 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2010 | 63 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 126 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 191 | 0.020 |
Why?
|
| Claudin-1 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 90 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2009 | 66 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 212 | 0.020 |
Why?
|
| Prostate | 1 | 2012 | 422 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2009 | 24 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 269 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 523 | 0.020 |
Why?
|
| Fertility | 1 | 2011 | 263 | 0.020 |
Why?
|
| Castration | 2 | 1978 | 31 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 2 | 1982 | 185 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 3 | 1976 | 46 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 479 | 0.020 |
Why?
|
| Memory | 1 | 2011 | 357 | 0.020 |
Why?
|
| Genotype | 1 | 1973 | 2525 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 371 | 0.020 |
Why?
|
| Thymidine | 3 | 1972 | 55 | 0.020 |
Why?
|
| Lymphoma | 1 | 1970 | 323 | 0.020 |
Why?
|
| Biological Transport | 2 | 2002 | 347 | 0.020 |
Why?
|
| Methods | 3 | 1975 | 150 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2002 | 799 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12043 | 0.020 |
Why?
|
| Carbon Isotopes | 3 | 1972 | 272 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 991 | 0.020 |
Why?
|
| Moloney murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
|
| Triticum | 2 | 1976 | 35 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 1986 | 38 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2006 | 35 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1986 | 91 | 0.020 |
Why?
|
| Temperature | 3 | 1976 | 304 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 286 | 0.020 |
Why?
|
| RNA Precursors | 1 | 1986 | 67 | 0.020 |
Why?
|
| Adipocytes | 1 | 2006 | 158 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1246 | 0.020 |
Why?
|
| Chromatography, Affinity | 2 | 1975 | 70 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 230 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1981 | 978 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2010 | 798 | 0.020 |
Why?
|
| Cell-Free System | 2 | 1975 | 106 | 0.020 |
Why?
|
| Research Design | 1 | 2008 | 646 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1986 | 449 | 0.010 |
Why?
|
| Insulin | 2 | 1985 | 1191 | 0.010 |
Why?
|
| Cyclin A | 1 | 2003 | 17 | 0.010 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 22 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2003 | 48 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2003 | 71 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1986 | 356 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2003 | 51 | 0.010 |
Why?
|
| Genes, myc | 1 | 2003 | 99 | 0.010 |
Why?
|
| Blastula | 1 | 2003 | 1 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2003 | 79 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 2003 | 13 | 0.010 |
Why?
|
| Gastrula | 1 | 2003 | 18 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 157 | 0.010 |
Why?
|
| Microvilli | 1 | 1983 | 73 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 316 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1983 | 284 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1983 | 152 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1986 | 747 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2003 | 180 | 0.010 |
Why?
|
| Nervous System | 1 | 2003 | 129 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1972 | 43 | 0.010 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1983 | 126 | 0.010 |
Why?
|
| Uridine | 2 | 1972 | 34 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2001 | 21 | 0.010 |
Why?
|
| Reproductive History | 1 | 2001 | 10 | 0.010 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2001 | 7 | 0.010 |
Why?
|
| Sheep | 1 | 1982 | 209 | 0.010 |
Why?
|
| Connexins | 1 | 2001 | 56 | 0.010 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 1972 | 18 | 0.010 |
Why?
|
| Growth Hormone | 1 | 2001 | 151 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 1981 | 11 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2001 | 122 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1983 | 469 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2002 | 136 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1980 | 41 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 637 | 0.010 |
Why?
|
| Metabolism | 2 | 1970 | 43 | 0.010 |
Why?
|
| Drug Antagonism | 1 | 1980 | 13 | 0.010 |
Why?
|
| Dibutyryl Cyclic GMP | 1 | 1980 | 1 | 0.010 |
Why?
|
| Spermidine | 1 | 1980 | 4 | 0.010 |
Why?
|
| Organ Transplantation | 1 | 2002 | 163 | 0.010 |
Why?
|
| Bucladesine | 1 | 1980 | 19 | 0.010 |
Why?
|
| Avian Myeloblastosis Virus | 2 | 1976 | 7 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 541 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1980 | 92 | 0.010 |
Why?
|
| Rabbits | 1 | 1980 | 716 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1980 | 249 | 0.010 |
Why?
|
| Lactose Synthase | 1 | 1978 | 1 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 1997 | 0.010 |
Why?
|
| Steroids | 1 | 1980 | 203 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 1213 | 0.010 |
Why?
|
| Nafoxidine | 1 | 1977 | 8 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1997 | 27 | 0.010 |
Why?
|
| Ploidies | 1 | 1997 | 38 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 6289 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1976 | 95 | 0.010 |
Why?
|
| Nucleic Acid Renaturation | 2 | 1973 | 8 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1976 | 54 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 2 | 1973 | 27 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 1973 | 44 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1997 | 156 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1980 | 1007 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1975 | 18 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1975 | 59 | 0.010 |
Why?
|
| Weaning | 1 | 1975 | 40 | 0.010 |
Why?
|
| Micropore Filters | 1 | 1974 | 7 | 0.010 |
Why?
|
| Avian Leukosis Virus | 1 | 1974 | 14 | 0.010 |
Why?
|
| Borohydrides | 1 | 1973 | 2 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1973 | 131 | 0.010 |
Why?
|
| Aminoisobutyric Acids | 1 | 1972 | 8 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1972 | 43 | 0.010 |
Why?
|
| Sarcoma, Experimental | 1 | 1972 | 16 | 0.010 |
Why?
|
| Valine | 1 | 1972 | 106 | 0.010 |
Why?
|
| Hexosephosphates | 1 | 1970 | 1 | 0.010 |
Why?
|
| Glucokinase | 1 | 1970 | 16 | 0.010 |
Why?
|
| Glycine | 1 | 1972 | 167 | 0.010 |
Why?
|
| Leucine | 1 | 1972 | 309 | 0.010 |
Why?
|
| Nucleosides | 1 | 1970 | 17 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 18783 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1978 | 119 | 0.000 |
Why?
|
| Middle Aged | 1 | 2008 | 25636 | 0.000 |
Why?
|
| Adult | 1 | 2008 | 28730 | 0.000 |
Why?
|
| Risk Factors | 1 | 2001 | 9901 | 0.000 |
Why?
|
| Amino Acids | 1 | 1970 | 660 | 0.000 |
Why?
|
| Testosterone | 1 | 1970 | 459 | 0.000 |
Why?
|
| RNA, Viral | 2 | 1978 | 540 | 0.000 |
Why?
|
| Karyotyping | 1 | 1982 | 338 | 0.000 |
Why?
|
| Placental Lactogen | 1 | 1978 | 3 | 0.000 |
Why?
|
| Cytarabine | 1 | 1978 | 99 | 0.000 |
Why?
|
| Fibroins | 1 | 1977 | 3 | 0.000 |
Why?
|
| Globins | 1 | 1977 | 35 | 0.000 |
Why?
|
| DNA Viruses | 1 | 1977 | 33 | 0.000 |
Why?
|
| Methylation | 1 | 1977 | 229 | 0.000 |
Why?
|
| Oviposition | 1 | 1975 | 6 | 0.000 |
Why?
|
| Mathematics | 1 | 1975 | 98 | 0.000 |
Why?
|
| Sepharose | 1 | 1974 | 15 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1974 | 94 | 0.000 |
Why?
|
| Drug Stability | 1 | 1973 | 55 | 0.000 |
Why?
|
| Cytosol | 1 | 1973 | 160 | 0.000 |
Why?
|
| Testis | 1 | 1974 | 407 | 0.000 |
Why?
|
| Uterus | 1 | 1974 | 590 | 0.000 |
Why?
|
| Liver | 1 | 1974 | 1851 | 0.000 |
Why?
|